Integer Holdings Corporation $ITGR Shares Sold by US Bancorp DE

US Bancorp DE decreased its position in Integer Holdings Corporation (NYSE:ITGR) by 21.0% during the 2nd quarter, Holdings Channel reports. The fund owned 9,332 shares of the medical equipment provider’s stock after selling 2,488 shares during the quarter. US Bancorp DE’s holdings in Integer were worth $1,148,000 as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. Bessemer Group Inc. raised its holdings in Integer by 73.1% during the first quarter. Bessemer Group Inc. now owns 296 shares of the medical equipment provider’s stock worth $35,000 after purchasing an additional 125 shares in the last quarter. SVB Wealth LLC acquired a new stake in Integer during the first quarter worth approximately $35,000. GAMMA Investing LLC raised its holdings in Integer by 20.2% during the second quarter. GAMMA Investing LLC now owns 796 shares of the medical equipment provider’s stock worth $98,000 after purchasing an additional 134 shares in the last quarter. Headlands Technologies LLC raised its holdings in Integer by 1,234.8% during the first quarter. Headlands Technologies LLC now owns 1,228 shares of the medical equipment provider’s stock worth $145,000 after purchasing an additional 1,136 shares in the last quarter. Finally, TD Private Client Wealth LLC raised its holdings in Integer by 5.8% during the first quarter. TD Private Client Wealth LLC now owns 1,524 shares of the medical equipment provider’s stock worth $180,000 after purchasing an additional 83 shares in the last quarter. Institutional investors and hedge funds own 99.29% of the company’s stock.

Integer Stock Performance

NYSE:ITGR opened at $104.87 on Friday. The firm’s fifty day moving average price is $104.91 and its 200 day moving average price is $113.12. Integer Holdings Corporation has a 1-year low of $99.54 and a 1-year high of $146.36. The company has a debt-to-equity ratio of 0.72, a current ratio of 3.41 and a quick ratio of 2.18. The firm has a market cap of $3.67 billion, a price-to-earnings ratio of 46.20, a price-to-earnings-growth ratio of 0.81 and a beta of 0.97.

Integer (NYSE:ITGR) last posted its quarterly earnings data on Thursday, July 24th. The medical equipment provider reported $1.55 earnings per share for the quarter, missing analysts’ consensus estimates of $1.57 by ($0.02). Integer had a net margin of 4.61% and a return on equity of 12.27%. The firm had revenue of $476.00 million during the quarter, compared to analysts’ expectations of $464.37 million. During the same quarter last year, the business earned $1.30 earnings per share. The business’s quarterly revenue was up 11.4% on a year-over-year basis. Integer has set its FY 2025 guidance at 6.250-6.510 EPS. On average, sell-side analysts expect that Integer Holdings Corporation will post 6.01 EPS for the current year.

Analyst Upgrades and Downgrades

ITGR has been the topic of a number of research analyst reports. Wells Fargo & Company cut their price objective on shares of Integer from $152.00 to $132.00 and set an “overweight” rating on the stock in a report on Friday, July 25th. Truist Financial cut their price objective on shares of Integer from $137.00 to $121.00 and set a “buy” rating on the stock in a report on Wednesday. Wall Street Zen raised shares of Integer from a “hold” rating to a “buy” rating in a report on Saturday, August 30th. Weiss Ratings restated a “hold (c)” rating on shares of Integer in a research report on Wednesday, October 8th. Finally, Raymond James Financial lowered their target price on shares of Integer from $150.00 to $143.00 and set an “outperform” rating on the stock in a research report on Friday, July 25th. One investment analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $137.29.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.